# FDA Inspection 972558 - SERIPHARM - May 06, 2016

Source: https://www.globalkeysolutions.net/records/fda_inspections/seripharm/733444d4-11e1-48f5-885c-986a5379c6af
Source feed: FDA_Inspections

> FDA Inspection 972558 for SERIPHARM on May 06, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 972558
- Company Name: SERIPHARM
- Inspection Date: 2016-05-06
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1273405 - 2021-03-12](https://www.globalkeysolutions.net/records/fda_inspections/seripharm/046b3ab9-6848-453f-8528-c2e2e36fac00)
- [FDA Inspection 1068502 - 2018-03-15](https://www.globalkeysolutions.net/records/fda_inspections/seripharm/a59f9cab-015b-43a5-ae9e-c749f14e8b08)
- [FDA Inspection 836916 - 2013-06-06](https://www.globalkeysolutions.net/records/fda_inspections/seripharm/23cd6c9a-13fa-4b32-844f-fcf0d7e31b1e)
- [FDA Inspection 646917 - 2010-01-29](https://www.globalkeysolutions.net/records/fda_inspections/seripharm/f930ba8e-c8ba-44b7-8db7-262697e6a87e)

Company: https://www.globalkeysolutions.net/companies/seripharm/b5349d82-bf7e-4e82-b09e-2c134d55df09

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c